Renaissance Technologies’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,079,515
| Closed | -$93K | – | 4288 |
|
|
2023
Q3 | $93K | Buy |
1,079,515
+384,600
| +55% | +$111K | ﹤0.01% | 3267 |
|
|
2023
Q2 | $389K | Sell |
694,915
-2,500
| -0.4% | -$2.21K | ﹤0.01% | 3003 |
|
|
2023
Q1 | $795K | Sell |
697,415
-17,800
| -2% | -$21.4K | ﹤0.01% | 2624 |
|
|
2022
Q4 | $801K | Sell |
715,215
-56,792
| -7% | -$90.5K | ﹤0.01% | 2666 |
|
|
2022
Q3 | $1.62M | Sell |
772,007
-68,500
| -8% | -$133K | ﹤0.01% | 2169 |
|
|
2022
Q2 | $1.14M | Sell |
840,507
-146,216
| -15% | -$212K | ﹤0.01% | 2619 |
|
|
2022
Q1 | $1.67M | Sell |
986,723
-369,051
| -27% | -$528K | ﹤0.01% | 2362 |
|
|
2021
Q4 | $1.46M | Buy |
1,355,774
+438,725
| +48% | +$712K | ﹤0.01% | 2380 |
|
|
2021
Q3 | $2.7M | Sell |
917,049
-56,053
| -6% | -$188K | ﹤0.01% | 1868 |
|
|
2021
Q2 | $2.93M | Buy |
973,102
+6,595
| +0.7% | +$20.2K | ﹤0.01% | 1993 |
|
|
2021
Q1 | $3.15M | Sell |
966,507
-56,700
| -6% | -$233K | ﹤0.01% | 1933 |
|
|
2020
Q4 | $4.22M | Buy |
1,023,207
+29,000
| +3% | +$167K | ﹤0.01% | 1701 |
|
|
2020
Q3 | $5.38M | Buy |
994,207
+42,900
| +5% | +$247K | 0.01% | 1529 |
|
|
2020
Q2 | $6.4M | Sell |
951,307
-71,400
| -7% | -$349K | 0.01% | 1484 |
|
|
2020
Q1 | $3.25M | Buy |
1,022,707
+512,595
| +100% | +$2.73M | ﹤0.01% | 1804 |
|
|
2019
Q4 | $3.57M | Buy |
510,112
+379,300
| +290% | +$2.02M | ﹤0.01% | 2048 |
|
|
2019
Q3 | $502K | Buy |
130,812
+94,400
| +259% | +$320K | ﹤0.01% | 2868 |
|
|
2019
Q2 | $138K | Buy |
+36,412
| New | +$121K | ﹤0.01% | 3362 |
|
Other funds holding RVLP
Renaissance Technologies's RVLP Position: Q4 2023 in Review
Renaissance Technologies sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2023, closing a stake of 1,079,515 shares — an estimated $93K sold.
Renaissance Technologies first reported a position in RVLP in Q2 2019 and held it in 18 quarters. The position peaked at $6.4M in Q2 2020. 3 funds tracked by Wall St. Rank hold RVLP as of Q4 2023.
- Renaissance Technologies reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2023 after selling out during the quarter.
- Renaissance Technologies sold 1,079,515 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2023, an estimated $93K.
- Renaissance Technologies first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q2 2019 and held it in 18 quarters.
- Renaissance Technologies's RVL Pharmaceuticals plc Ordinary Shares position peaked at $6.4M in Q2 2020.
- 3 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2023.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.